22nd Century (XXII)
NASDAQ:XXII
Want to see XXII full AI Analyst Report?
XXII Stock Chart & Stats
$0.76
-$0.08(-1.39%)
At close: 4:00 PM EST
$0.76
-$0.08(-1.39%)
Day’s Range― - ―
52-Week Range$1.57 - $489.90
Previous CloseN/A
Volume40.32K
Average Volume (3M)2.49M
Market Cap
$1.20M
Enterprise Value-$2.66M
Total Cash (Recent Filing)$7.15M
Total Debt (Recent Filing)$4.21M
Price to Earnings (P/E)―
Beta2.54
Next Earnings
Apr 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.89
Shares Outstanding721,338
10 Day Avg. Volume328,967
30 Day Avg. Volume2,485,312
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.13
Price to Sales (P/S)0.12
P/FCF Ratio-0.27
Enterprise Value/Market Cap-2.21
Enterprise Value/Revenue-0.15
Enterprise Value/Gross Profit0.75
Enterprise Value/Ebitda0.25
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.9
Revenue Forecast (FY)$32.50M
Bulls Say, Bears Say
Bulls Say
Material Debt ReductionLeverage falling to under $1M materially reduces fixed interest and covenant risk, improving financial flexibility. Over 2-6 months this lowers default probability, gives management more runway to execute commercial plans, and makes future non-dilutive financing or partnerships more feasible.
Proprietary IP And Branded VLN ProductsOwning proprietary tobacco genetics and launching VLN® brands creates structural differentiation versus commodity suppliers. Branded, IP-backed products and licensing potential support higher gross margins, pricing power, and recurring revenue streams if adoption and distribution scale over the next several quarters.
2025 Revenue Rebound And Improving GrossA ~70% revenue rebound and gross profit recovering to roughly break-even indicate renewed commercial traction and early operating leverage. If the company sustains this top-line momentum and preserves higher-margin channels, it establishes a more durable path to narrow operating losses over several quarters.
Bears Say
Persistent Negative Operating And Free Cash FlowContinued negative OCF/FCF means the business does not self-fund growth or working capital needs. Even with improved burn, recurring cash deficits increase reliance on external capital, constrain investment in commercialization, and raise the probability of further dilutive financings within months.
Chronic Unprofitability And Weak MarginsDeep and persistent operating losses signal structural issues in cost base or pricing. Despite 2025 improvement, negative EBIT and volatile revenues show profitability is not yet sustainable, threatening equity value and limiting the company's ability to self-finance strategic initiatives over the medium term.
Thin Equity Cushion And Dilutive Preferred FinancingA modest equity cushion (~$2.7M) combined with a structured Series B preferred that converts and carries warrant coverage creates substantial dilution risk for common holders. Protective investor terms and liquidation priority can limit common shareholder recovery and constrain strategic flexibility going forward.
22nd Century News
XXII FAQ
What was 22nd Century’s price range in the past 12 months?
22nd Century lowest stock price was $1.57 and its highest was $489.90 in the past 12 months.
What is 22nd Century’s market cap?
22nd Century’s market cap is $1.20M.
When is 22nd Century’s upcoming earnings report date?
22nd Century’s upcoming earnings report date is Apr 30, 2026 which is tomorrow.
How were 22nd Century’s earnings last quarter?
22nd Century released its earnings results on Mar 26, 2026. The company reported -$5.89 earnings per share for the quarter, missing the consensus estimate of -$2.1 by -$3.79.
Is 22nd Century overvalued?
According to Wall Street analysts 22nd Century’s price is currently Overvalued.
Does 22nd Century pay dividends?
22nd Century does not currently pay dividends.
What is 22nd Century’s EPS estimate?
22nd Century’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does 22nd Century have?
22nd Century has 721,338 shares outstanding.
What happened to 22nd Century’s price movement after its last earnings report?
22nd Century reported an EPS of -$5.89 in its last earnings report, missing expectations of -$2.1. Following the earnings report the stock price went down -10.638%.
Which hedge fund is a major shareholder of 22nd Century?
Currently, no hedge funds are holding shares in XXII
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
22nd Century
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
XXII Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant strategic progress and financial improvements, such as becoming debt-free and expanding higher-margin branded products. However, the company continues to face challenges with ongoing losses and a decline in revenue. While the balance sheet has strengthened, the timeline to profitability remains uncertain. The sentiment is cautiously optimistic with notable achievements but balanced by current financial challenges.View all XXII earnings summariesTechnical Analysis
Universal
―
Turning Point Brands
―
Greenlane Holdings
―
Kaival Brands Innovations Group
―
Ispire Technology, Inc.
―
Ownership Overview
35.11% Insiders
0.64% Mutual Funds
<0.01% Other Institutional Investors
64.24% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---